Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TTK HEALTHCARE   MYLAN
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-23
MYLAN
Dec-18
TTK HEALTHCARE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,1063,967-   
Low Rs6682,184-   
Sales per share (Unadj.) Rs513.21,825.4-  
Earnings per share (Unadj.) Rs31.649.6-  
Cash flow per share (Unadj.) Rs40.7391.3-  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs674.71,974.7-  
Shares outstanding (eoy) m14.13514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.71.7 102.6%   
Avg P/E ratio x28.062.0 45.2%  
P/CF ratio (eoy) x21.87.9 277.4%  
Price / Book Value ratio x1.31.6 84.4%  
Dividend payout %31.60-   
Avg Mkt Cap Rs m12,5291,582,214 0.8%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m1,2340-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m7,251939,158 0.8%  
Other income Rs m4830-   
Total revenues Rs m7,734939,158 0.8%   
Gross profit Rs m313243,019 0.1%  
Depreciation Rs m128175,847 0.1%   
Interest Rs m5245,170 0.1%   
Profit before tax Rs m61622,002 2.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m170-3,500 -4.8%   
Profit after tax Rs m44725,502 1.8%  
Gross profit margin %4.325.9 16.7%  
Effective tax rate %27.5-15.9 -173.0%   
Net profit margin %6.22.7 226.9%  
BALANCE SHEET DATA
Current assets Rs m10,664524,425 2.0%   
Current liabilities Rs m2,108382,364 0.6%   
Net working cap to sales %118.015.1 780.1%  
Current ratio x5.11.4 368.9%  
Inventory Days Days1384 15.3%  
Debtors Days Days46493 496.8%  
Net fixed assets Rs m994182,181 0.5%   
Share capital Rs m141500 28.3%   
"Free" reserves Rs m9,3930-   
Net worth Rs m9,5341,015,998 0.9%   
Long term debt Rs m01,096,588 0.0%   
Total assets Rs m11,6582,725,301 0.4%  
Interest coverage x12.81.5 858.4%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.60.3 180.5%   
Return on assets %4.32.6 165.1%  
Return on equity %4.72.5 186.7%  
Return on capital %7.03.2 220.6%  
Exports to sales %9.10-   
Imports to sales %1.40-   
Net fx Rs m4940-   
CASH FLOW
From Operations Rs m-261195,157 -0.1%  
From Investments Rs m330-100,875 -0.3%  
From Financial Activity Rs m-124-90,916 0.1%  
Net Cashflow Rs m-551,617 -3.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare TTK HEALTHCARE With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare TTK HEALTHCARE With: IOL CHEMICALS & PHARM.  WANBURY  LINK PHARMA  SMS LIFESCIENCES INDIA  ZENITH HEALTH  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.